← Back to Intel
Insider ActivityLTRN
Schalop Lee Troy, Director at Lantern Pharma Inc., bought $100K of LTRN
Updated Jun 14, 2026
Schalop Lee Troy
Director
Lantern Pharma Inc. ·
$LTRN
Transaction Details
| Insider | Schalop Lee Troy |
|---|---|
| Title | Director |
| Company | Lantern Pharma Inc. |
| Ticker | LTRN |
| Transaction Type | Purchase |
| Transaction Date | 2026-05-12 |
| Shares Traded | 48,544 |
| Price Per Share | $2.06 |
| Total Value | $100K |
| Filed Date | 2026-05-14 |
| Accession Number | 0001493152-26-023083 |
Ownership Context
| Shares Owned After Transaction | 48,544 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001493152-26-023083
Other Insider Trades — LTRN
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| KEYSER D JEFFREY | Director | bought | $100K | 2026-05-12 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for LTRN — Lantern Pharma Inc. →
Track LTRN insider activity in real time on The Wire →
Get alerts when Schalop Lee Troy files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:11 UTC